UNSPSC 85705112: Removal of autologous tissue substitute from right toe phalanx, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from right toe phalanx, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QPQ07Z

UNSPSC 85705112, Removal of autologous tissue substitute from right toe phalanx, open approach, is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The recent opportunities in the source—independent medical evaluation services, surgical benefit carve-outs, occupational medical surveillance, specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—address administrative medical services, healthcare networks, and personnel placement rather than a specific surgical procedure on a toe phalanx. The code itself names a narrowly defined surgical intervention, but state and local buyers posting opportunities under this code are soliciting broad healthcare services administration and staffing. The mismatch suggests either a cataloging error in how opportunities were tagged or a drift between the code's surgical procedure scope and its current operational use in state and local procurement systems.

No recent opportunities directly solicit removal of autologous tissue substitute from right toe phalanx or procedurally related orthopedic surgery services. The opportunities instead represent health plan administration, occupational health programs, and workforce staffing across multiple jurisdictions—the City of Phoenix (Arizona), City of Long Beach (California), Washington State Department of Transportation, Harris County (Texas), Collier County (Florida), and Santa Clara County (California)—indicating geographic and issuing-body dispersion but no meaningful activity concentration under the code as named. A firm evaluating pursuit under this code should clarify the actual scope intended before investing in proposal development.